Citius Oncology
0 followers
CTOR
Performance
About Citius Oncology
Citius Oncology, Inc. is a biopharmaceutical company focused on developing and commercializing innovative targeted oncology therapies. It emphasizes precision immune-oncology approaches and has a FDA-approved therapy, LYMPHIR, for relapsed or refractory cutaneous T-cell lymphoma (CTCL). The company is a majority-owned subsidiary of Citius Pharmaceuticals, Inc. and operates with corporate offices in Cranford, New Jersey.